LAS VEGAS, Dec. 27, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC) http://www.samaritanpharma.com), a biopharmaceutical company focused on developing innovative therapeutics in the areas of CNS, cancer, cardiovascular, and infectious diseases, announces Samaritan management has proven their ability to continue on a successful path to commercial breakthrough drugs and Samaritan's 2008 prognosis looks good.
